Hartwick’s TBRM students complete research projects with real life implications for patients with respiratory illness, Parkinson’s disease, rheumatoid arthritis, and diabetes.
Our students’ research projects were accepted for presentation at the Association for Clinical and Translational Science (ACTS) Virtual Conference. To be accepted, TBRM projects must demonstrate an impact with the potential to advance the study of disease and treatment.
Attendance, participation and presentation of original research at national conferences are career building opportunities and a significant way to broaden knowledge in the TBRM field. Here’s a quick look at their remarkable research:
Melatonin use and occurrence of respiratory illnesses
Hannah Bowen G’22, Zachary A.P. Wintrob, Alice C. Ceacareanu
Study Impact: These research findings suggest that use of melatonin could alleviate virus-induced respiratory illnesses. This data positions melatonin as a drug candidate in the fight against COVID-19.
Statin use and medical expenditure in patients with Parkinson’s disease
Anthony Lo Piccolo G’22, Alice C. Ceacareanu, Zachary A.P. Wintrob
Study impact: This study unveiled very unexpected evidence: despite their clinical benefits reported in patients with Parkinson’s, statins use was not associated with cost savings. The data indicates that the main driver of expenditure in these patients is correlated with the specific type and duration of cholesterol treatment.
Monoclonal antibody use in rheumatoid arthritis: an evaluation of medical expenditure
Robert A. Kelly G’22, Alice C. Ceacareanu, Zachary A.P. Wintrob
Study impact: This research project shows that younger patients receiving biologics for rheumatoid arthritis have higher medical expenditures. While unknown yet, this evidence may indicate the indirect cost of the immense societal benefit enabled by making these drugs available to younger patients diagnosed with severe RA.
Insulin use and depigmentation: a survey of real-world evidence
James Lukasik ’23, G’24, Zachary A.P. Wintrob, G. Emilia Costin, Alice C. Ceacareanu
Study impact: This research is the first to show that long-acting insulin containing protamine is more likely to be associated with skin depigmentation. Such findings are unprecedented clues towards elucidating the root cause and the mechanism of vitiligo occurrence.